Advertisement

METABIOTICS pp 93-102 | Cite as

Conclusion

  • Boris A. Shenderov
  • Alexander V. Sinitsa
  • Mikhail M. Zakharchenko
  • Christine Lang
Chapter
  • 20 Downloads

Abstract

As regards cell quantitative content, a human being is essentially a more prokaryotic than eukaryotic organism. Great success has been achieved in the characterization of microorganisms inhabiting the human being, all their genetic elements have been explored in detail by using leading-edge molecular sequencing techniques. The state of “host-its microbiota” system is one of the leading factors that determine the growth, development and health of a human being; the importance of the microbiome in the pathogenesis, phenotype, prognosis of many diseases has been established. Symbiotic (indigenous) microorganisms inhabiting his/her skin and mucosa are a source of various low molecular weight compounds involved in environmental perception, in bacterial information intra- and intercellular exchange both among themselves and with the host cells, in the regulation of physiological functions, biochemical and behavioral responses. Different strains form their own strain-specific range of similar substrates, co-factors, enzymes and regulatory molecules which bear chemical and functional similarity with those produced by the host’s eukaryotic cells and numerous micronutrients contained in food products. It means that many compounds of microbial origin should be viewed as universal low molecular weight substrates and co-factors of epigenetic, metabolic, immune, neurohormonal reactions, diffuse regulatory endocrine system (APUD system) and the participants of intra- and interpopulation communication between bacteria and the host eukaryotic cells. Bioactive molecules of microbial origin are capable of interaction with the host cells through binding to the receptors of membranes, mitochondria, ribosomes. These molecules can also be accumulated in intracellular exosomes and regulate intercellular and intracellular channels, influencing the structure, synthesis, transfer and function of regulatory and signaling molecules (Shenderov 2014; Shenderov 2016; Aguilar-Toaláa et al. 2018; Bik et al. 2018; Engevik and Versalovic 2017; Gilbert et al. 2016; Lebeer et al. 2018; Maguire and Maguire 2019; Shenderov 2011a; Shenderov 2011b; Shenderov 2013; Singh et al. 2018).

Bibliography

  1. Aguilar-Toaláa JE, Garcia-Varela R, Garcia HS, Mata-Harod V, González-Córdovaa AF et al. Postbiotics: An evolving term within the functional foods field. Trends in Food Science & Technology. 2018;75:105–114. doi: https://doi.org/10.1016/j.tifs.2018.03.009.CrossRefGoogle Scholar
  2. Bik EM, Ugalde JA, Cousins J, Goddard AD, Richman J, Apte ZS. Microbial biotransformations in the human distal gut. British J Pharmacology. 2018;175(24):4404–4414. doi: https://doi.org/10.1111/bph.14085.CrossRefGoogle Scholar
  3. Browne HP, Forster SC, Anonye BO, Kumar N, Neville BA et al. Culturing of “unculturable” human microbiota reveals novel taxa and extensive sporulation. Nature. 2016;533:543–546. doi: https://doi.org/10.1038/nature17645.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Cani PD Human gut microbiome: hopes, threats and promises. Gut. 2018;67:1716–1725. doi: https://doi.org/10.1136/gutjnl-2018-316723.CrossRefPubMedPubMedCentralGoogle Scholar
  5. Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ. Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis. 2015;26:26191. doi: https://doi.org/10.3402/mehd.v26.26191.CrossRefPubMedGoogle Scholar
  6. Dorrestein PC, Mazmanian SK, Knight R. Finding the missing links among metabolites, microbes, and the host. Immunity. 2014;40:824–832. doi: https://doi.org/10.1016/j.immuni.2014.05.015.CrossRefPubMedPubMedCentralGoogle Scholar
  7. Engevik MA, Versalovic J. Biochemical feature of beneficial microbes: foundation for therapeutic microbiology. Microbial Spectr. 2017;5(5). doi: https://doi.org/10.1128/microbiolspec.BAD-0012-2016.
  8. Gilbert JA, Quinn RA, Debelius J, Morton J, Garg N et al. Microbiome-wide association studies link dynamic microbial consortia to disease. Nature. 2016;535:94–103. doi: https://doi.org/10.1038/nature18850.CrossRefGoogle Scholar
  9. Golovenko OV, Khalif AO, Golovenko AO. The role of butyric acid in the treatment of organic and functional diseases of the colon. Clinical prospects of gastroenterology, hepatology. 2011;3:20–29 (in Russian).Google Scholar
  10. Hunt RH, Xiao SD, Megraud F, Leon-Barua R, Bazzoli F et al. Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. J Gastrointestin Liver Dis. 2011;20(3):299–304.PubMedGoogle Scholar
  11. Karczewski KJ, Snyder MP. Integrative omics for health and disease. Nature Reviews Genetics. 2018;19(5):299–309. doi: https://doi.org/10.1038/nrg.2018.4.CrossRefPubMedPubMedCentralGoogle Scholar
  12. Lebeer S, Bron PA, Marco ML, Van Pijkeren JP, O’Conell Motherway M et al. Identification of probiotic effect or molecules: present state and future perspectives. Curr Opin Biotechnol. 2018;49:217–223. doi: https://doi.org/10.1016/j.copbio.2017.10.007.CrossRefPubMedGoogle Scholar
  13. Maguire M, Maguire G. Gut dysbiosis, leaky gut, and intestinal epithelial proliferation in neurological disorders: towards the development of a new therapeutic using amino acids, prebiotics, probiotics, and postbiotics. Rev Neurosci. 2019;30(2):179–201. doi: https://doi.org/10.1515/revneuro-2018-0024.CrossRefPubMedGoogle Scholar
  14. Martin FPJ, Wang Y, Sprenger N, Yap IK, Lundstedt T et al. Probiotic modulation of symbiotic gut microbial-host metabolic interactions ib a humanized microbiome mouse model. Molecular Systems Biology. 2008;4:157. doi: https://doi.org/10.1038/msb4100190.CrossRefPubMedPubMedCentralGoogle Scholar
  15. Osipov GA, Verkhovtseva NV. Study of human microecology by mass-spectrometry of microbial markers. Benefic Microbes. 2011;2(1):63–78. doi: https://doi.org/10.3920/BM2010.0017.CrossRefGoogle Scholar
  16. Paul B, Barnes S, Demark-Wahnefried W, Morrow C, Salvador C et al. Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases. Clinical Epigenetics. 2015;7:112. doi: https://doi.org/10.1186/s13148-015-0144-7.CrossRefPubMedPubMedCentralGoogle Scholar
  17. Rajilic-Stojanovic M, de Vos WM. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev. 2014;38:996–1047. doi: https://doi.org/10.1111/1574-6976.12075.CrossRefPubMedPubMedCentralGoogle Scholar
  18. Sharma M, Shukla G. Metabiotics: One Step ahead of Probiotics; an Insight into Mechanisms Involved in Anticancerous Effect in Colorectal Cancer. Front. Microbiol. 2016;7:1940. doi: https://doi.org/10.3389/fmicb.2016.01940.CrossRefPubMedPubMedCentralGoogle Scholar
  19. Shenderov BA, Gakhova EN, Kaurova SA, Uteshev VK, Shishova NV. Cryobanks of natural symbiotic microbiocenosis and their importance in medicine and biotechnology. Biophysics of live cell. 2014;10:221–223 (in Russian).Google Scholar
  20. Shenderov BA, Ivanova YaV, Sorokina IM. Complex food product enrichment. PATENT RF 2397246. 2010 (in Russian).Google Scholar
  21. Shenderov BA, Manvelova MA, Gahova EN, Piorunski DA. Functional food and cryobanks of microbiocenoses-practical applications of gnotobiology in the 21st century. In: Hashimoto K et al, editors. Germfree life and its ramifications. Japan: Shiozawa; 1996. p. 533–536.Google Scholar
  22. Shenderov BA. Functional food, cryobanks of microbial associations and their role in the preservation and restoration of health. Journal of Restorative Medicine & Rehabilitation. 2003;3:29–31 (in Russian).Google Scholar
  23. Shenderov BA. Functional nutrition and its role in the prevention of metabolic syndrome. Moscow: DeLi print; 2008 (in Russian).Google Scholar
  24. Shenderov BA. Metabiotics — novel prophylactic technology of diseases associated with microecological imbalance of human being. Journal of Restorative Medicine & Rehabilitation. 2017;4:40–49 (in Russian).Google Scholar
  25. Shenderov BA. Molecular language of probiotic microorganisms. Food ingredients: Raw materials & additives. 2009;1:47–48 (in Russian).Google Scholar
  26. Shenderov BA. OMIC-technologies and their importance in current prophylactic and regenerative medicine. Journal of Restorative Medicine & Rehabilitation. 2012;3:70–78 (in Russian).Google Scholar
  27. Shenderov BA. Probiotic (symbiotic) bacterial languages. Anaerobe. 2011a;17(6):490–495. doi: https://doi.org/10.1016/j.anaerobe.2011.05.009.CrossRefGoogle Scholar
  28. Singh A, Vishwakarma V, Singhal B. Metabiotics: The Functional Metabolic Signatures of Probiotics: Current State-of-Art and Future Research Priorities — Metabiotics: Probiotics Effector Molecules. Advan Biosci Biotechnol. 2018;9(4):147–189. doi: https://doi.org/10.4236/abb.2018.94012.CrossRefGoogle Scholar
  29. Sonnenburg JL, Backhed F. Diet-microbiota interactions as moderators of human metabolism. Nature. 2016;535(7610):56–64. doi: https://doi.org/10.1038/nature18846.CrossRefPubMedPubMedCentralGoogle Scholar
  30. Suvorov A, Karaseva A, Kotyleva M, Kondratenko Y, Lavrenova H et al. Autoprobiotics as an approach for restoration of personalized microbiota. Front Microbiol. 2018;9:1869. doi: https://doi.org/10.3389/fmicb.2018.01869.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Boris A. Shenderov
    • 1
  • Alexander V. Sinitsa
    • 2
  • Mikhail M. Zakharchenko
    • 2
  • Christine Lang
    • 3
  1. 1.Research Laboratory for Design & Implementation of Personalized Nutrition-Related Product & DietsK.G. Razumovsky University of Technology & ManagementMoscowRussia
  2. 2.Kraft Ltd.St. PetersburgRussia
  3. 3.MBCC GroupBerlinGermany

Personalised recommendations